Efficacy and safety of Levetiracetam treatment in patients suffering from Restless Legs SyndromeEficacia y seguridad de un tratamiento con levetiracetam en pacientes con síndrome idiopático de piernas inquietas
- Conditions
- Restless legs syndrome (RLS)
- Registration Number
- EUCTR2005-001516-41-ES
- Lead Sponsor
- Clínica Plató Fundació Privada
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
1. Male and female older than 30 years old.
2. Patients with idiopathic RLS.
3. RLS diagnostic according to protocol of center.
4. Score scale according International Restless Study Group.
3. Patients must give their written consent to participate in the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1. Patients with secondary RLS.
2. Pregnant or breast-feeding.
3. Renal impairment.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method